[ET Net News Agency, 4 March 2024] CSTONE PHARMA-B (02616) fell 20.9% to HK$1.17.
It hits an intra-day low of HK$1.17, hitting a historical low, and an intra-day high of
HK$1.47. The total shares traded was 3.17 million, with a value of HK$4.14m. The active
buy/sell ratio is 37:63, with net selling turnover of HK$1.01m. FUTU SEC INT'L accounts
for greatest net responsive buying turnover of HK$363,345, with volume weighted average
price of HK$1.338. CHINA INV INFO accounts for greatest net responsive selling turnover of
HK$482,970, with volume weighted average price of HK$1.311. The stock has fallen a
combined 26.9% over the past 2 consecutive trading days.
Basic Information
=================
---------------------------------
Nominal 1.170 % Chg -20.95%
High 1.470 Low 1.170
Shares Tr 3.17m Turnover 4.14m
10-D SMA 1.536 %H.V 69.322
20-D SMA 1.550 VWAP 1.306
50-D SMA 1.851 RSI14 24.660
---------------------------------
Status: Hitting a historical low, active buy/sell ratio is 37:63, with net selling
turnover of HK$1.01m, falling a combined 26.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSTONE PHARMA-B (02616) 1.17 -20.95
GENSCRIPT BIO (01548) 16.10 +3.87
INNOVENT BIO (01801) 40.40 +1.76
EVEREST MED-B (01952) 24.55 +1.24
LAEKNA-B (02105) 8.20 +12.95
WUXI XDC (02268) 22.25 +19.24
WUXI BIO (02269) 20.55 +9.31
TIGERMED (03347) 28.30 +3.85
BEIGENE (06160) 99.20 +2.22
SKB BIO-B (06990) 116.20 +12.05
-----------------------------------------------
(ed)